+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
Healthy Volunteers
ID07203287

Comparing Safety of Rocuronium with Sugammadex versus Cisatracurium with Neostigmine in Anesthesia for Patients with Chronic Kidney Disease

Led by The University of Texas Medical Branch, Galveston · Updated on 2026-10-20

490

Participants Needed

1

Research Sites

34 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare the safety of two combinations of neuromuscular blocking agents and reversal agents used during anesthesia in patients with chronic kidney disease. The main question is whether using Cisatracurium with neostigmine results in fewer post-operative lung complications compared to Rocuronium with sugammadex. Both treatment approaches are standard care practices for neuromuscular blockade and reversal during surgery. Participants will be randomly assigned to one of two groups one group will receive Rocuronium and Sugammadex, while the other will receive Cisatracurium and Neostigmine. Both groups will undergo general anesthesia with endotracheal intubation and appropriate neuromuscular blockade and reversal according to standard regimens. After surgery, patients will be monitored in the recovery room or intensive care unit as planned. Participants will be observed for up to 7 days after surgery for any signs of respiratory complications, such as atelectasis, hypoxia, respiratory distress or failure, pneumonia, and pneumothorax. Researchers will also track hospital length of stay, time spent in post-anesthesia care, and any cardiac instability during this period. The study is randomized and single-blinded, with all care related to the study provided under medical supervision.

CONDITIONS

Brief Title

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

Research Team

M

Michael Kinsky, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here